Cited by 366Pharmacogenetics and Drug MetabolismGlutathione Transferases and PolymorphismsDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie”

Open access

Riches, Zoe, Stanley, Emma L., Bloomer, Jackie C., Coughtrie, Michael W.H.·2009·Drug Metabolism and Disposition

DOI 10.1124/dmd.109.028399PMC PMC2774979

Open this paper in CoChat — free account

Abstract

Expression levels of the major human sulfotransferases (SULTs) involved in xenobiotic detoxification in a range of human tissues (i.e., SULT "pies") are not available in a form allowing comparison between tissues and individuals. Here we have determined, by quantitative immunoblotting, expression levels for the five principal human SULTs-SULT1A1, SULT1A3/4, SULT1B1, SULT1E1, and SULT2A1-and determined the kinetic properties toward probe substrates, where available, for these enzymes in cytosol samples from a bank of adult human liver, small intestine, kidney, and lung. We produced new isoform-selective antibodies against SULT1B1 and SULT2A1, which were used alongside antibodies against SULT1A3 and SULT1A1 previously produced in our laboratory or available commercially (SULT1E1). Expression levels were derived using purified recombinant enzymes to construct standard curves for each individual isoform and immunoblot. Substantial intertissue and interindividual differences in expression were observed. SULT1A1 was the major enzyme (>50% of total, range 420-4900 ng/mg cytosol protein) in the liver, followed by SULT2A1, SULT1B1, and SULT1E1. SULT1A3 was completely absent from this tissue. In contrast, the small intestine contained the largest overall amount of SULT of any of the tissues, with SULT1B1 the major enzyme (36%), closely followed by SULT1A3 (31%), and SULT1A1, SULT1E1, and SULT2A1 more minor forms (19, 8, and 6% of total, respectively). The kidney and lung contained low levels of SULT. We provide a unique data set that will add value to the study of the role and contribution of sulfation to drug and xenobiotic metabolism in humans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1124/dmd.109.028399

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 2×
“Immunochemical quantification of expression profiles has been carried out for the cytochromes P450 (P450s) in liver (Shimada et al., 1994) and intestine (Paine et al.”
BackgroundMethod
THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
Paine, M. F., Hart, H. L., Ludington, S. S., Haining, R. L., Rettie, A. E., & Zeldin, D. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008672 · Cited by 870
Human Sulfotransferases and Their Role in Chemical Metabolism
Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj061 · Cited by 703
Sulfonation and molecular action
Strott, C. A. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0040 · Cited by 487
Potent Inhibition of Estrogen Sulfotransferase by Hydroxylated PCB Metabolites: A Novel Pathway Explaining the Estrogenic Activity of PCBs
Kester, M. H. A., Bulduk, S., Tibboel, D., Meinl, W., Glatt, H. R., Falany, C. N., Coughtrie, M. W. H., Bergman, Å., Safe, S. H., Kuiper, G. G. J. M., et al. (2000) · Endocrinology · doi:10.1210/endo.141.5.7530 · Cited by 384
Sulfotransferases in the bioactivation of xenobiotics
Glatt, H. R. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00202-7 · Cited by 355
A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily
Blanchard, R. L., Freimuth, R. R., Buck, J., Weinshilboum, R. M., & Coughtrie, M. W. H. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00009 · Cited by 320

Flagged first, then by citations

Show all 51 references

Sorted by citations

The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2013) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 594
The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids
Cassidy, A., & Minihane, A. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.136051 · Cited by 522
The Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419
PBPK models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Aarons, L. J., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O. J. D., Jamei, M., Lloyd, R. S., Pepin, X. J. H., Rostami‐Hodjegan, A., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.008 · Cited by 322
Resveratrol and Its Human Metabolites—Effects on Metabolic Health and Obesity
Springer, M., & Moco, S. (2019) · Nutrients · doi:10.3390/nu11010143 · Cited by 293
In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects
Sjögren, E., Abrahamsson, B., Augustijns, P., Becker, D., Bolger, M. B., Brewster, M. E., Brouwers, J., Flanagan, T. R., Harwood, M. D., Heinen, C., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.010 · Cited by 287
Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME
Yang, Z., Kulkarni, K. H., Zhu, W., & Hu, M. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833107 · Cited by 271
Endogenous and exogenous mediators of quercetin bioavailability
Guo, Y., & Bruno, R. S. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.008 · Cited by 263
Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation
Cione, E., Torre, C. L., Cannataro, R., Caroleo, M. C., Plastina, P., & Gallelli, L. (2019) · Molecules · doi:10.3390/molecules25010063 · Cited by 263
Genistein: Its role in metabolic diseases and cancer
Mukund, V., Mukund, D., Sharma, V., Mannarapu, M., & Alam, A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.09.004 · Cited by 251
Bioaccessibility and bioavailability of phenolic compounds
Shahidi, F., & Peng, H. (2018) · Journal of Food Bioactives · doi:10.31665/jfb.2018.4162 · Cited by 253
A Review of Factors Affecting Anthocyanin Bioavailability: Possible Implications for the Inter-Individual Variability
Eker, M. E., Aaby, K., Budić-Leto, I., Brnčić, S. R., El, S. N., Karakaya, S., Şimşek, Ş., Manach, C., Wiczkowski, W., & de Pascual‐Teresa, S. (2019) · Foods · doi:10.3390/foods9010002 · Cited by 230
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“The liver also shows high SULT expression and activity compared to other tissues, including SULT2A1 and SULT2B1 involved in androgen metabolism (Meloche and Falany, 2001; Riches et al., 2009).”
The role of drug metabolizing enzymes in clearance
Di, L. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.876006 · Cited by 216
Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity
Chang, S., Weber, E. J., Sidorenko, V. S., Chapron, A., Yeung, C. K., Gao, C., Mao, Q., Shen, D. D., Wang, J., Rosenquist, T. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95978 · Cited by 180
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
Lai, Y., Chu, X., Di, L., Gao, W., Guo, Y., Liu, X., Lu, C., Mao, J., Shen, H., Tang, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.009 · Cited by 182
Prevalence of Non–Cytochrome P450–Mediated Metabolism in Food and Drug Administration–Approved Oral and Intravenous Drugs: 2006–2015
Cerny, M. A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070763 · Cited by 157
Scientific Committee on Consumer Safety SCCS
On, O. (2014) · Cited by 155
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Vinarov, Z., Abrahamsson, B., Artursson, P., Batchelor, H. K., Berben, P., Bernkop‐Schnürch, A., Butler, J., Ceulemans, J., Davies, N. M., Dupont, D., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.001 · Cited by 162
Function and organization of the human cytosolic sulfotransferase (SULT) family
Coughtrie, M. W. H. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.005 · Cited by 142
Self-citation
Phenolic sulfates as new and highly abundant metabolites in human plasma after ingestion of a mixed berry fruit purée
Pimpão, R. C., Ventura, M. R., Ferreira, R. B., Williamson, G., & Santos, C. N. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514003511 · Cited by 126
Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease
Hardwick, R. N., Ferreira, D. W., More, V. R., Lake, A. D., Lu, Z. J., Manautou, J. E., Slitt, A. L., & Cherrington, N. J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048439 · Cited by 126
Prediction of Human Drug Clearance by Multiple Metabolic Pathways: Integration of Hepatic and Intestinal Microsomal and Cytosolic Data
Cubitt, H., Houston, J., & Galetin, A. (2011) · Drug Metabolism And Disposition · doi:10.1124/dmd.110.036566 · Cited by 125
Sulfation pathways from red to green
Günal, S., Hardman-Kavanaugh, R. E., Kopřiva, S., & Mueller, J. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007422 · Cited by 117
The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug Clearance
Miners, J. O., Yang, X., Knights, K., & Zhang, L. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.757 · Cited by 119
Interactions of cytosolic sulfotransferases with xenobiotics
James, M. O., & Ambadapadi, S. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.835613 · Cited by 113
Contribution of Intestinal Cytochrome P450-Mediated Metabolism to Drug-Drug Inhibition and Induction Interactions
Galetin, A., Gertz, M., & Houston, J. B. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.28 · Cited by 113
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
Järvinen, E., Deng, F. Y., Kiander, W., Sinokki, A., Kidron, H., & Sjöstedt, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.802539 · Cited by 118
Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro–in vivo extrapolation of oral drug absorption
Harwood, M. D., Neuhoff, S., Carlson, G., Warhurst, G., & Rostami‐Hodjegan, A. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1810 · Cited by 111
Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry Perspective
Bohnert, T., Patel, A. H., Templeton, I. E., Chen, Y., Lu, C., Lai, G., Leung, L. Y., Tse, S., Einolf, H. J., Wang, Y.-H., et al. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.069096 · Cited by 109
Expression, regulation and function of intestinal drug transporters: an update
Müller, J., Keiser, M., Droździk, M., & Oswald, S. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0259 · Cited by 114
Regioselective Sulfation and Glucuronidation of Phenolics: Insights into the Structural Basis
Wu, B., Basu, S., Meng, S., Wang, X., & Hu, M. (2011) · Current Drug Metabolism · doi:10.2174/138920011797470100 · Cited by 107
Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump
Rodrigues, A. D., Lai, Y., Cvijic, M. E., Elkin, L. L., Zvyaga, T. A., & Soars, M. G. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054205 · Cited by 107
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models
Peters, S. A., Jones, C. R., Ungell, A.-L. B., & Hatley, O. J. D. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0351-6 · Cited by 108
Phase II Metabolism of Hesperetin by Individual UDP-Glucuronosyltransferases and Sulfotransferases and Rat and Human Tissue Samples
Brand, W., Boersma, M. G., Bik, H., den Hil, E. F. H.-V., Vervoort, J. J. M., Barron, D., Meinl, W., Glatt, H. R., Williamson, G., van BLADEREN, P. J., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031047 · Cited by 99
Genome-wide Association Study of Estradiol Levels and the Causal Effect of Estradiol on Bone Mineral Density
Schmitz, D., Ek, W. E., Berggren, E., Höglund, J., Karlsson, T., & Johansson, Å. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab507 · Cited by 94
Genistein: Dual Role in Women’s Health
Yu, L. C., Rios, E., Castro, L., Liu, J., Yan, Y., & Dixon, D. (2021) · Nutrients · doi:10.3390/nu13093048 · Cited by 95
Inhibition of Thyroid Hormone Sulfotransferase Activity by Brominated Flame Retardants and Halogenated Phenolics
Butt, C. M., & Stapleton, H. M. (2013) · Chemical Research in Toxicology · doi:10.1021/tx400342k · Cited by 96
Regulation of the cytosolic sulfotransferases by nuclear receptors
Runge‐Morris, M., Kocarek, T. A., & Falany, C. N. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.748794 · Cited by 90
Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human
Basit, A., Neradugomma, N. K., Wolford, C. C., Fan, P. W., Murray, B. P., Takahashi, R., Khojasteh, S. C., Smith, B. J., Heyward, S. A., Totah, R. A., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00559 · Cited by 89
Topics on Drug Metabolism
Paxton, J. W. (2012) · InTech eBooks · doi:10.5772/1180 · Cited by 90
Extrahepatic metabolism at the body's internal–external interfaces
Gundert‐Remy, U., Bernauer, U., Blömeke, B., Döring, B., Fabian, E. J., Goebel, C., Hessel‐Pras, S., Jäckh, C., Lampen, A., Oesch, F., et al. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.900565 · Cited by 87
From Endogenous Compounds as Biomarkers to Plasma‐Derived Nanovesicles as Liquid Biopsy; Has the Golden Age of Translational Pharmacokinetics‐Absorption, Distribution, Metabolism, Excretion‐Drug–Drug Interaction Science Finally Arrived?
Rodrigues, D., & Rowland, A. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1328 · Cited by 80
Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum
Tucker, T. G. H. A., Milne, A., Fournel‐Gigleux, S., Fenner, K. S., & Coughtrie, M. W. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.017 · Cited by 78
Expression of clinically relevant drug‐metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra‐subject analysis
Fritz, A., Busch, D., Łapczuk-Romańska, J., Ostrowski, M., Droździk, M., & Oswald, S. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13137 · Cited by 79
The Gate That Governs Sulfotransferase Selectivity
Cook, I. T., Wang, T., Almo, S. C., Kim, J., Falany, C. N., & Leyh, T. S. (2012) · Biochemistry · doi:10.1021/bi301492j · Cited by 79
The Role of Canalicular ABC Transporters in Cholestasis
Cuperus, F. J. C., Claudel, T., Gautherot, J., Halilbasic, E., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056358 · Cited by 76
Pork Production with Entire Males: Directions for Control of Boar Taint
Squires, E. J., Bone, C., & Cameron, J. (2020) · Animals · doi:10.3390/ani10091665 · Cited by 73
Determination of Serotonin and Dopamine Metabolites in Human Brain Microdialysis and Cerebrospinal Fluid Samples by UPLC-MS/MS: Discovery of Intact Glucuronide and Sulfate Conjugates
Suominen, T., Uutela, P., Ketola, R. A., Bergquist, J., Hillered, L., Finel, M., Zhang, H., Laakso, A., & Kostiainen, R. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068007 · Cited by 71
Evaluation of Human Hepatocytes Cultured by Three-dimensional Spheroid Systems for Drug Metabolism
Ohkura, T., Ohta, K., Nagao, T., Kusumoto, K., Koeda, A., Ueda, T., Jomura, T., Ikeya, T., Ozeki, E., Wada, K., et al. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rg-105 · Cited by 71
In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker
Yamasaki, H., Kawaguchi, N., Nonaka, M., Takahashi, J., Morohashi, A., Hirabayashi, H., Moriwaki, T., & Asahi, S. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1203505 · Cited by 69
The Role of Catecholamines in Pathophysiological Liver Processes
Lelou, E., Corlu, A., Nesseler, N., Rauch, C., Mallédant, Y., Séguin, P., & Aninat, C. (2022) · Cells · doi:10.3390/cells11061021 · Cited by 73
Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases
Barbosa, A. C. S., Feng, Y., Yu, C., Huang, M., & Xie, W. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1588884 · Cited by 66
Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery
Konings, G. F. J., Brentjens, L. S., Delvoux, B., Linnanen, T., Cornel, K. M. C., Koskimies, P., Bongers, M. Y., Kruitwagen, R. F. P. M., Xanthoulea, S., & Romano, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00940 · Cited by 66
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution
Darwich, A. S., Pade, D., Ammori, B. J., Jamei, M., Ashcroft, D. M., & Rostami‐Hodjegan, A. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01538.x · Cited by 66
Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
Yalcin, E. B., More, V. R., Neira, K. L., Lu, Z. J., Cherrington, N. J., Slitt, A. L., & King, R. J. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.050930 · Cited by 63
PBPK Modeling of Intestinal and Liver Enzymes and Transporters in Drug Absorption and Sequential Metabolism
Fan, J., Chen, S., Chow, E. C. Y., & Pang, K. S. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328931 · Cited by 63
Bioactivation of the human carcinogen aristolochic acid
Sidorenko, V. S., Attaluri, S., Zaitseva, I., Iden, C. R., Dickman, K. G., Johnson, F., & Grollman, A. P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu095 · Cited by 61
Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring
Lemmens, G., Camp, A. V., Kourula, S., Vanuytsel, T., & Augustijns, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020161 · Cited by 58
Mass Spectrometry-Based Targeted Proteomics as a Tool to Elucidate the Expression and Function of Intestinal Drug Transporters
Oswald, S., Gröer, C., Droździk, M., & Siegmund, W. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9521-3 · Cited by 60
Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2
Herrmann, K., Engst, W., Meinl, W., Florian, S., Cartus, A. T., Schrenk, D., Appel, K. E., Nolden, T., Himmelbauer, H., & Glatt, H. R. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt408 · Cited by 59
Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes
Darwich, A. S., Henderson, K., Burgin, A., Ward, N., Whittam, J., Ammori, B. J., Ashcroft, D. M., & Rostami‐Hodjegan, A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04284.x · Cited by 57
The Clock Protein Bmal1 Regulates Circadian Expression and Activity of Sulfotransferase 1a1 in Mice
Guo, L., Yu, F., Zhang, T., & Wu, B. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082503 · Cited by 56
Bioactivation of 3-n-Butylphthalide via Sulfation of Its Major Metabolite 3-Hydroxy-NBP: Mediated Mainly by Sulfotransferase 1A1
Diao, X., Pang, X., Xie, C., Guo, Z., Zhong, D., & Chen, X. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056218 · Cited by 55
Generation of Enterocyte-Like Cells with Pharmacokinetic Functions from Human Induced Pluripotent Stem Cells Using Small-Molecule Compounds
Iwao, T., Kodama, N., Kondo, Y., Kabeya, T., Nakamura, K., Horikawa, T., Niwa, T., Kurose, K., & Matsunaga, T. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062604 · Cited by 53
Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer
den Braver-Sewradj, S. P., den Braver, M. W., Vermeulen, N. P. E., Commandeur, J. N. M., Richert, L., & Vos, J. C. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.02.013 · Cited by 54
Phase II Drug Metabolism
Janov, P., & iller, M. (2012) · InTech eBooks · doi:10.5772/29996 · Cited by 51
Fluorescent probes for bioactive detection and imaging of phase II metabolic enzymes
Feng, L., Ning, J., Tian, X., Wang, C., Zhang, L., Ma, X., & James, T. D. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.213026 · Cited by 50
Waterpipe smoke: A considerable source of human exposure against furanic compounds
Schubert, J., Bewersdorff, J., Luch, A., & Schulz, T. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.10.012 · Cited by 49
SULT genetic polymorphisms: physiological, pharmacological and clinical implications
Kurogi, K., Rasool, M. I., Alherz, F. A., Daibani, A. A. E., Bairam, A. F., Abunnaja, M. S., Yasuda, S., Wilson, L. J., Hui, Y., & Liu, M. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1940952 · Cited by 54
Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism
Zhang, H., Basit, A., Busch, D., Yabut, K. C. B., Bhatt, D. K., Droździk, M., Ostrowski, M., Li, A. P., Collins, C. J., Oswald, S., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.003 · Cited by 48
Metabolism of drugs and other xenobiotics
Anzenbacher, P., & Zanger, U. M. (2012) · Wiley-VCH eBooks · Cited by 48
Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism
Isvoran, A., Peng, Y., Ceauranu, S., Schmidt, L., Nicot, A. B., & Miteva, M. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103349 · Cited by 52
Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells
Wu, Y., Chitranshi, P., Loukotková, L., da Costa, G. G., Beland, F. A., Zhang, J., & Fang, J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1893-6 · Cited by 47
Review on the Use of Cell Cultures to Study Metabolism, Transport, and Accumulation of Flavonoids: From Mono‐Cultures to Co‐Culture Systems
Gonzales, G. B., Camp, J. V., Vissenaekens, H., Raes, K., Smagghe, G. J., & Grootaert, C. (2015) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12158 · Cited by 49
A Nucleotide-Gated Molecular Pore Selects Sulfotransferase Substrates
Cook, I. T., Wang, T., Falany, C. N., & Leyh, T. S. (2012) · Biochemistry · doi:10.1021/bi300631g · Cited by 45
Crystal structures of human sulfotransferases: insights into the mechanisms of action and substrate selectivity
Dong, D., Ako, R., & Wu, B. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.677027 · Cited by 45
Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer
Leung, A. W. Y., Backstrom, I., & Bally, M. B. (2016) · Oncotarget · doi:10.18632/oncotarget.10046 · Cited by 45
Bioactivation of food genotoxicants 5-hydroxymethylfurfural and furfuryl alcohol by sulfotransferases from human, mouse and rat: a comparative study
Sachse, B., Meinl, W., Sommer, Y., Glatt, H. R., Seidel, A., & Monien, B. H. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1392-6 · Cited by 43
High Accuracy in Silico Sulfotransferase Models
Cook, I. T., Wang, T., Falany, C. N., & Leyh, T. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510974 · Cited by 46
Sulfation of melatonin: Enzymatic characterization, differences of organs, species and genders, and bioactivity variation
Tian, X., Huo, X., Dong, P., Wu, B., Wang, X., Wang, C., Liu, K., & Ma, X. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.02.010 · Cited by 47
Determination, intercorrelation and intraindividual stability of five steroids in hair, saliva and urine among chinese college students
Chen, Z., Zhang, Q., Chen, S., Wang, W., Liu, G., & Deng, H. (2019) · Steroids · doi:10.1016/j.steroids.2019.05.010 · Cited by 43
Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels
Tremmel, R., Herrmann, K., Engst, W., Meinl, W., Klein, K., Glatt, H. R., & Zanger, U. M. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1955-4 · Cited by 42
Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity
Al‐Dujaili, E. A. S., Kenyon, C. J., Nicol, M. R., & Mason, J. I. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.011 · Cited by 41
Steroid Sulfation in Neurodegenerative Diseases
Vítků, J., Hill, M., Kolátorová, L., Havrdová, E., & Kancheva, R. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.839887 · Cited by 42
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Henriques, B. C., Yang, E. H., Lapetina, D. L., Carr, M. S., Yavorskyy, V., Hague, J., & Aitchison, K. J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.491895 · Cited by 40
Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1
Mueller, J. W., Idkowiak, J., Gesteira, T. F., Vallet, C., Hardman-Kavanaugh, R. E., van den Boom, J., Dhir, V., Knauer, S. K., Rosta, E., & Arlt, W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002248 · Cited by 39
Mechanisms of the Different DNA Adduct Forming Potentials of the Urban Air Pollutants 2-Nitrobenzanthrone and Carcinogenic 3-Nitrobenzanthrone
Stiborová, M., Martínek, V., Svobodová, M., Šístková, J., Dvořák, Z., Jitka Ulrichová, A., Šimánek, V., Frei, E., Schmeiser, H. H., Phillips, D. H., et al. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100052d · Cited by 38
Transit and Metabolic Pathways of Quercetin in Tubular Cells: Involvement of Its Antioxidant Properties in the Kidney
Muñoz-Reyes, D., Morales, A. I., & Prieto, M. (2021) · Antioxidants · doi:10.3390/antiox10060909 · Cited by 43
Estragole: A weak direct-acting food-borne genotoxin and potential carcinogen
Martins, C., Cação, R., Cole, K. J., Phillips, D. H., Laires, A., Rueff, J., & Rodrigues, A. S. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2012.04.009 · Cited by 38
Cytosolic Sulfotransferase 1A3 Is Induced by Dopamine and Protects Neuronal Cells from Dopamine Toxicity
Sidharthan, N. P., Minchin, R. F., & Butcher, N. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493239 · Cited by 39
Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines
Eagle, K. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.03.004 · Cited by 35
Structure, dynamics and selectivity in the sulfotransferase family
Leyh, T. S., Cook, I. T., & Wang, T. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.835625 · Cited by 35
Bisphenol A sulfonation is impaired in metabolic and liver disease
Yalcin, E. B., Kulkarni, S. R., Slitt, A. L., & King, R. J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.009 · Cited by 35
Why We Need Proper PBPK Models to Examine Intestine and Liver Oral Drug Absorption
Chow, E. C. Y., & Pang, K. S. (2012) · Current Drug Metabolism · doi:10.2174/1389200211309010057 · Cited by 45
Lymphatic metabolites of quercetin after intestinal administration of quercetin-3-glucoside and its aglycone in rats
Nakamura, T., Kinjo, C., Nakamura, Y., Kato, Y., Nishikawa, M., Hamada, M., Nakajima, N., Ikushiro, S., & Murota, K. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.03.024 · Cited by 35
Developmental Expression of the Cytosolic Sulfotransferases in Human Liver
Dubaisi, S., Caruso, J. A., Gaedigk, R., Vyhlidal, C. A., Smith, P. C., Hines, R. N., Kocarek, T. A., & Runge‐Morris, M. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086363 · Cited by 35
Altered tissue distribution of 2-amino-1-methyl-6-phenylimidazo[4,5- b ]pyridine-DNA adducts in mice transgenic for human sulfotransferases 1A1 and 1A2
Dobbernack, G., Meinl, W., Schade, N., Florian, S., Wend, K., Voigt, I., Himmelbauer, H., Gross, M., Liehr, T., & Glatt, H. R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr204 · Cited by 34
Sulfation of opioid drugs by human cytosolic sulfotransferases: Metabolic labeling study and enzymatic analysis
Kurogi, K., Chepak, A., Hanrahan, M. T., Liu, M., Sakakibara, Y., Suiko, M., & Liu, M.-C. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.003 · Cited by 34
To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics
Bosgra, S., Vlaming, M. L. H., & Vaes, W. H. J. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0308-9 · Cited by 33

Authors: Riches, Z., Stanley, E. L., Bloomer, J. C., & Coughtrie, M. W. H.
Affiliations: University of Dundee (GB)
ORCID: Riches, Zoe
Coughtrie, Michael W.H.
Venue: Drug Metabolism and Disposition
Publisher: Elsevier BV
Published: 2009-11
Volume: 37
Issue: 11
Pages: 2255-2261
ISSN: 0090-9556 (ISSN-L)
DOI: 10.1124/dmd.109.028399
PMC: PMC2774979
OpenAlex: W2155462152
Cited by: 365
References: 51
Citations by year: 2026: 10 · 2025: 14 · 2024: 15 · 2023: 18 · 2022: 21 · 2021: 26 · 2020: 19 · 2019: 20 · 2018: 26 · 2017: 33 · 2016: 28 · 2015: 27 · 2014: 31 · 2013: 22 · 2012: 30
FWCI: 16.39
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Drug Metabolism and Disposition (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion)
Funders: Biotechnology and Biological Sciences Research Council (BBS/S/B/2004/11767)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: sulfotransferase, SULT1A1, SULT1A3, SULT1B1, SULT1E1, SULT2A1, sulfation, xenobiotic detoxification, tissue-specific enzyme expression, interindividual variability, enzyme kinetics, human liver, small intestine, kidney, lung, drug metabolism
MeSH terms: Adult, Aged, Enzyme Activation, Female, Humans, Intestine, Small, Isoenzymes, Kidney, Liver, Lung, Male, Middle Aged, Tissue Distribution, Sulfotransferases, Gene Expression Regulation, Enzymologic, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie”

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks